Perrigo introduces generic Aleve Liquid Gels

ALLEGAN, Mich. — Perrigo on Monday launched a store-brand version of Bayer Healthcare’s Aleve Liquid Gels, 220 mg.

Aleve Liquid Gels generated annual sales of approximately $80 million, Perrigo stated, citing SymphonyIRI Group data.

"This approval is another example of Perrigo's commitment to bring new products to market,” stated Perrigo's chairman and CEO Joseph Papa. Perrigo noted that it is the first-to-market with a generic equivalent of the Aleve Liquid Gels.